PRTN3 and rheumatoid arthritis: Several studies and multiple scientific evidences have focused in particular on ACPA autoantibodies considered more sensitive and specific for diagnostic and prognostic purposes as early indicators of joint destruction, persistent RA and extra-articular involvement [7, 8].